Arundhati Parmar

At the annual Medicarians conference in Las Vegas that draws brokers, agents, agency owners and field marketing organizations, among others, Dawn Maroney suggested that payers are not always the “bad guys.”

Ed Park is sincere and passionate about his calling as the CEO of Devoted Health, which provides Medicare Advantage plans to seniors in 29 states. But it remains to be seen if he can do more or the same with less.

An independent orthopedic surgeon in New York is claiming that he is being unfairly pushed out of a regional hospital owned by Mount Sinai Health System.

An independent orthopedic surgeon in New York is claiming that he is being unfairly pushed out of a regional hospital owned by Mount Sinai Health System.

This year, we are hosting a new event called Bullseye: Targeting Healthier Outcomes & Returns on July 23 in Chicago. It's invitation-only and exclusively for healthcare investors and corporate business development leads. Join the waitlist for a chance to be in the room with your peers.

Jason Prestinario talks about the state of healthcare interoperability today, while also addressing questions about the interoperability lawsuits he and others are involved in against Epic.

While there are growing efforts to link dental health with overall health, the urgency should be felt strongly not only by pregnant women but, more importantly, by their care providers and health insurance companies. For instance, pregnant women with gum disease are 3-4 times more likely to develop pre-eclampsia, an emergency condition.

UnitedHealthcare CEO Tim Noel, Optum CEO Dr. Patrick Conway, and other top executives and employees gave unprecedented access to journalists and others in order to show how the company is trying to reduce friction in healthcare. The goal was to change hearts and minds. Did the insurance behemoth succeed?

In this month's pivot podcast, I speak to the chief medical officer of San Francisco-based Vynca, an innovative company in the world of palliative care that is providing serious disease management at home.

Many startups and established companies focused on drug testing on human data in preclinical studies have been boosted by FDA's move away from reliance on animal testing towards organoid, organ-on-a-chip, and other in silico technologies. A Connecticut startup believes whole-organ testing should be an essential part of this mix.